Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks.

Source:http://linkedlifedata.com/resource/pubmed/id/15150579

Br. J. Cancer 2004 Jun 14 90 12 2268-77

Download in:

View as

General Info

PMID
15150579